uFraction8

A unique solution to suit the demands of perfusion culture clarification applications for both monoclonal antibody and viral vector production processes.

Microfluidics device for labs by uFraction8

uFraction8 was founded in London in December 2016 by Brian Miller and Monika Tomecka, who met through the Deep Science Ventures accelerator program.

uFraction8 will receive funding from Poland’s innovation funding agency, NCBiR, to deliver a project worth over €2 million over the course of the next two and a half years.

NCBiR has awarded this project to uFraction8 for the research, development and acceleration of our technology into the market.

uFraction8 has a vision to enable the global transition to sustainable bio-based manufacture to help feed and maintain the health of people and ecosystems.

The company offers technology consultations, demos, and discussions about customer requirements.

uFraction8 develops microfluidics-based filter systems for energy-efficient and scalable bioprocessing in biomanufacturing.

uFraction8 secures £3.4 million in funding to advance its microfiltration technology. The investment is led by Foresight Group, with additional support from PARP. The company plans to use the funds to scale commercialization efforts for its filtration solutions.

Mar 2025biopharminternational.comNews article

uFraction8 raises £3.4 million in a funding round led by Foresight Group. The investment supports the Scottish biotech company’s growth and development. Details on the company’s focus or use of funds are not specified in the article.

Mar 2025Drug Discovery World (DDW)News article

uFraction8 secures £3.4 million in seed funding to advance its bio-separation technology. Foresight’s Ventures team leads the round, joined by Old College Capital, Scottish Enterprise, Alwyn Capital, and existing investor Thia Ventures. The funding supports the company’s development in bioprocessing solutions.

Feb 2025foresight.groupNews article

A Falkirk-based biotech company raises £2.5 million to scale its bio-separation technology for pharmaceutical and food production. The funding supports commercialization efforts targeting manufacturers in both industries. The technology likely streamlines separation processes in drug or food ingredient production.

Jan 2022Insider.co.ukNews article